US Broker Ratings

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring an 80.20% Upside Potential in the Health Information Services Sector

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a notable player in the healthcare sector, specifically within the health information services industry. This California-based company, with a market capitalization of $941.59..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Uncovering a 75.85% Upside Potential in the RNA Medicine Arena

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the healthcare sector, specifically in biotechnology, with its innovative approach to RNA medicine. Based in Singapore, this clinical-stage company is..

Biohaven Ltd. (BHVN) Stock Analysis: Promising 80% Upside Amidst Innovative Biotech Pipeline

Biohaven Ltd. (BHVN) stands out in the healthcare sector, specifically within the biotechnology industry, for its innovative approach to developing therapies in immunology, neuroscience, and oncology. With a market capitalization..

Opko Health, Inc. (OPK) Stock Analysis: A Look at Growth Potential and Analyst Ratings

Opko Health, Inc. (NASDAQ: OPK) operates within the healthcare sector, focusing on diagnostics and pharmaceuticals. The Miami-based company, with a market capitalization of $1.06 billion, provides a diverse range of..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A Biotech Gem with 86% Potential Upside

In the ever-evolving landscape of the biotechnology sector, Ocular Therapeutix, Inc. (OCUL) stands out as a company with a compelling narrative and significant growth prospects. Headquartered in Bedford, Massachusetts, Ocular..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 28.76% Potential Upside Amid Innovative Biotechnology Ventures

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands as a prominent player in the biotechnology sector, focusing on groundbreaking advancements in cellular metabolism medicines. With a market capitalization of $1.45 billion, this..

Omnicell, Inc. (OMCL) Stock Analysis: Exploring a 12.69% Upside Potential

Omnicell, Inc. (NASDAQ: OMCL), a pivotal player in the healthcare sector specializing in medication management solutions, has captured investor attention with its promising growth metrics and potential upside of 12.69%...

Arcutis Biotherapeutics (ARQT) Stock Analysis: Growth Potential in Dermatology with a 5.77% Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is making waves in the biotechnology sector, particularly in the field of dermatology. With a current market capitalization of $3.66 billion, this biopharmaceutical company is..

BGM Group Ltd. (BGM): Navigating Challenges in the Healthcare Sector

For investors keeping an eye on the healthcare sector, BGM Group Ltd. (BGM) presents an intriguing case. Situated within China’s dynamic market, BGM operates in the specialized niche of drug..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A 35% Potential Upside with Robust Revenue Growth

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is capturing the attention of individual investors with its impressive 35.34% potential upside, as indicated by its average target price of $109.25 against the current..

Evolent Health, Inc (EVH) Stock Analysis: Unpacking a 153% Potential Upside with Strong Buy Ratings

Evolent Health, Inc. (NYSE: EVH), a prominent player in the healthcare sector, specifically within the health information services industry, presents a compelling investment opportunity with its significant potential upside. With..

The Pennant Group, Inc. (PNTG) Stock Analysis: A Healthcare Contender with 23% Upside Potential

The Pennant Group, Inc. (NASDAQ: PNTG), a notable player in the healthcare sector, is gaining attention from investors with its promising potential upside of 23.37%. Specializing in medical care facilities,..

agilon health, inc. (AGL) Stock Analysis: Navigating a 34% Potential Upside in the Healthcare Sector

agilon health, inc. (NYSE: AGL) is a healthcare company that has carved out a niche in providing services for seniors through partnerships with primary care physicians across the United States...

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 56.88% Potential Upside in the Healthcare Sector

Astrana Health Inc. (NASDAQ: ASTH), a dynamic player in the healthcare sector, has caught the attention of investors due to its impressive growth potential and significant upside opportunity. With a..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unveiling Growth Potential in the Medical Device Sector

Establishment Labs Holdings Inc (NASDAQ: ESTA) is carving a niche in the healthcare sector with its innovative medical devices, focusing on aesthetic and reconstructive plastic surgeries. As a company headquartered..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Deep Dive into Its 87% Potential Upside

Investors tracking the biotechnology sector may want to pay close attention to Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage company dedicated to advancing treatment options for neuromuscular diseases. With a..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Biotech with 57% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing the attention of investors with its promising pipeline and substantial upside potential. Operating in the dynamic biotechnology sector, this clinical-stage global biopharmaceutical company..

NewAmsterdam Pharma (NAMS) Stock Analysis: Biotech Giant with 31% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a key player in the healthcare sector with a specialization in biotechnology, has been making waves in the investment world. This Netherlands-based company, with..

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Exploring a 13.38% Upside Potential Amidst Challenging Metrics

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, is renowned for its innovative dental solutions and equipment. With a market capitalization of $2.25 billion, this Charlotte,..

Novavax, Inc. (NVAX) Stock Analysis: Unveiling an 85% Upside Potential in the Biotech Sector

In the dynamic world of biotechnology, Novavax, Inc. (NASDAQ: NVAX) stands out as a company with intriguing potential despite recent challenges. With a market capitalization of $1.12 billion and a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds